Search Results

Your search for S. MONICA SONI, MD, AND ANDREW A. HERTLER, MD, FACP,S. MONICA SONI, MD, AND ANDREW A. HERTLER, MD, FACP matches 2 pages

Showing 1 - 2

By The ASCO Post Staff / August 25, 2023

More on the Complexity of Prior Authorization

We read with interest the recent commentary by S. Monica Soni, MD, and Andrew A. Hertler, MD, FACP, on prior authorization (June 10, 2023, issue of The ASCO Post). The nuances of prior authorization in our health-care landscape are both complex and consequential. Conceived as a safeguard against...

issues in oncology

By S. MONICA SONI, MD, AND ANDREW A. HERTLER, MD, FACP / June 10, 2023

Rethinking Prior Authorization

Prior authorization of medical procedures, services, and medications has been a standard requirement of health-care providers for decades. Rising health-care costs, specifically the escalating prices of cancer drug therapies, have led to a new focus by payers, providers, and policymakers on prior...

May

Today In Oncology

Search Results

Your search for S. MONICA SONI, MD, AND ANDREW A. HERTLER, MD, FACP,S. MONICA SONI, MD, AND ANDREW A. HERTLER, MD, FACP matches 2 pages

More on the Complexity of Prior Authorization

Rethinking Prior Authorization

USPSTF Issues Final Recommendation Statement on Screening for Breast Cancer

Relapsed or Refractory CD7-Positive Leukemia or Lymphoma CAR T-Cell Therapy Plus HSCT Without GVHD Prophylaxis

Premastectomy Radiotherapy, Surgery, and Immediate Breast Reconstruction

Liposomal Irinotecan vs Topotecan in Relapsed Small Cell Lung Cancer

Smoking Cessation Regimens: Does Dose of Therapy Matter?